Anna R. GiulianoPhD
Dr. Anna R. Giuliano is the founding Director of the Center for Immunization and Infection Research in Cancer (CIIRC) at the Moffitt Cancer Center and Research Institute and is an expert in this field with a long and successful record of NIH funding. Her career had its inception in the relationship between human papillomavirus (HPV) infections and cervical cancer in women and has evolved over the past 28 years to encompass HPV and penile, anal, and oral cancers in men, as well as other infectious diseases and their causal relationships with various cancers.
Dr. Giuliano’s work has contributed significantly to our understanding of the rate at which HPV infections are acquired and cleared, the proportion that progress to disease, as well as HPV vaccine protection against multiple diseases in women and men. She has been actively involved in cancer epidemiology and prevention studies conducted among diverse populations in the U.S. and abroad and, as such, was a contributor to the 1999 Institute of Medicine (IOM) report entitled, The Unequal Burden of Cancer and the 2005 International Agency for Research on Cancer (IARC) report which concluded for the first time that HPV is a cause of multiple cancers in women and men.
Dr. Giuliano has been honored to receive two important awards from the American Cancer Society (ACS). In 2013, at the ACS 100th anniversary, she was the recipient of the ACS Distinguished Achievement in Cancer Award. In 2018, she was selected for the ACS Clinical Research Professor Award for “Prevention of Infection-Related Cancers.” Dr. Giuliano is the author of more than 370 peer-reviewed publications and has been continuously funded by the NIH since 1990.